144,407 members

Skip to content. | Skip to navigation

News

NHS England concludes wide-ranging deal for cystic fibrosis drugs

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

NHS England concludes wide-ranging deal for cystic fibrosis drugs

NHS England has announced it has secured a definitive agreement with Vertex Pharmaceuticals to make available all three of their UK-licensed cystic fibrosis medicines.

This means NHS patients will now have full access to Orkambi, Symkevi and Kalydeco, and around 5000 people may now take up these treatments. There is no cap on patient numbers, and each and every patient in England who might benefit can now get these treatments free on the NHS. Clinicians will be able to begin prescribing these drugs within 30 days. More.....